BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16018428)

  • 1. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.
    Engemann JJ; Friedman JY; Reed SD; Griffiths RI; Szczech LA; Kaye KS; Stryjewski ME; Reller LB; Schulman KA; Corey GR; Fowler VG
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):534-9. PubMed ID: 16018428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.
    Reed SD; Friedman JY; Engemann JJ; Griffiths RI; Anstrom KJ; Kaye KS; Stryjewski ME; Szczech LA; Reller LB; Corey GR; Schulman KA; Fowler VG
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):175-83. PubMed ID: 15756889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
    Inrig JK; Reed SD; Szczech LA; Engemann JJ; Friedman JY; Corey GR; Schulman KA; Reller LB; Fowler VG
    Clin J Am Soc Nephrol; 2006 May; 1(3):518-24. PubMed ID: 17699254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost.
    McGarry SA; Engemann JJ; Schmader K; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2004 Jun; 25(6):461-7. PubMed ID: 15242192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?
    Abramson MA; Sexton DJ
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):408-11. PubMed ID: 10395142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes.
    Chu VH; Crosslin DR; Friedman JY; Reed SD; Cabell CH; Griffiths RI; Masselink LE; Kaye KS; Corey GR; Reller LB; Stryjewski ME; Schulman KA; Fowler VG
    Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
    Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters.
    Sedlacek M; Gemery JM; Cheung AL; Bayer AS; Remillard BD
    Am J Kidney Dis; 2007 Mar; 49(3):401-8. PubMed ID: 17336701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with the development of bacteremia with Staphylococcus aureus.
    Troidle L; Eisen T; Pacelli L; Finkelstein F
    Hemodial Int; 2007 Jan; 11(1):72-5. PubMed ID: 17257359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
    Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
    Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
    Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
    Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site.
    Lentino JR; Baddour LM; Wray M; Wong ES; Yu VL
    Infection; 2000; 28(6):355-60. PubMed ID: 11139154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients.
    Li Y; Friedman JY; O'Neal BF; Hohenboken MJ; Griffiths RI; Stryjewski ME; Middleton JP; Schulman KA; Inrig JK; Fowler VG; Reed SD
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):428-34. PubMed ID: 19118117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.
    Mokrzycki MH; Zhang M; Cohen H; Golestaneh L; Laut JM; Rosenberg SO
    Nephrol Dial Transplant; 2006 Apr; 21(4):1024-31. PubMed ID: 16449293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients.
    Greiner W; Rasch A; Köhler D; Salzberger B; Fätkenheuer G; Leidig M
    Clin Microbiol Infect; 2007 Mar; 13(3):264-8. PubMed ID: 17391380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between patients under hemodialysis with community-onset bacteremia caused by community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus strains.
    Wu HS; Kuo SC; Chen LY; Chiang MC; Lin YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2013 Apr; 46(2):96-103. PubMed ID: 22520272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
    Shinefield H; Black S; Fattom A; Horwith G; Rasgon S; Ordonez J; Yeoh H; Law D; Robbins JB; Schneerson R; Muenz L; Fuller S; Johnson J; Fireman B; Alcorn H; Naso R
    N Engl J Med; 2002 Feb; 346(7):491-6. PubMed ID: 11844850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study.
    Nielsen LH; Jensen-Fangel S; Benfield T; Skov R; Jespersen B; Larsen AR; Østergaard L; Støvring H; Schønheyder HC; Søgaard OS
    BMC Infect Dis; 2015 Jan; 15():6. PubMed ID: 25566857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.